Cellebrite DI (CLBT) — Cash Flow Reinvestment Rate
Cellebrite DI (CLBT) has a Cash Flow Reinvestment Rate of 1.20x as of December 2025, reinvesting $98.66 Million (capex $3.96 Million plus investments $-94.70 Million) from operating cash flow of $82.23 Million. See Cellebrite DI free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cellebrite DI Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Cellebrite DI across 7 annual periods. For the full cash flow conversion analysis, see how efficiently does Cellebrite DI generate cash.
Annual Cash Flow Reinvestment Rate for Cellebrite DI (2019–2025)
Year-by-year capital reinvestment analysis for Cellebrite DI. See Cellebrite DI free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.71x | $120.79 Million | $168.96 Million | $13.22 Million | ▼ -41.0% |
| 2024 | 1.21x | $160.08 Million | $132.17 Million | $10.61 Million | ▲ +73.9% |
| 2023 | 0.70x | $71.06 Million | $102.06 Million | $7.92 Million | ▼ -85.7% |
| 2022 | 4.88x | $100.32 Million | $20.58 Million | $9.09 Million | ▲ +115.8% |
| 2021 | 2.26x | $81.45 Million | $36.05 Million | $8.11 Million | ▲ +616.9% |
| 2020 | 0.32x | $20.96 Million | $66.51 Million | $6.18 Million | ▼ -89.1% |
| 2019 | 2.90x | $46.72 Million | $16.13 Million | $6.21 Million | — |